Uytengsu-Hamilton 22q11 Neuropsychiatry Research Awards

The Stanford Maternal and Child Health Research Institute (MCHRI) Uytengsu-Hamilton 22q11 Neuropsychiatry Research Program aims to promote research to improve the neurocognitive outcomes and behavioral symptoms of 22q11 Deletion Syndrome with immediate (within 5 years) and long term impact.

This program supports a wide range of scientific approaches from basic stem cell biology, clinical translational research to integrated medicine and data science, for up to 2 years of funding that could best (or only) be performed by faculty from different disciplines. Faculty from different schools are encouraged to work together on these initiatives, and strongly promote collaborations between basic and physician scientists. Learn more here.

FY 2020 Awards

Vinod Menon, PhD
Professor, Psychiatry & Behavioral Sciences
Study Title: Leveraging Big Data and Using Deep Learning Neural Networks to Predict Progression of Psychosis in 22q11 DS

Alexander Urban, PhD
Assistant Professor, Psychiatry & Behavioral Sciences and Genetics
Study Title: A Genome Analysis Method to Detect and Resolve the Exact Boundaries of the 22q11 Deletion

Thomas Sudhof, MD
Associate Professor, Molecular and Cellular Physiology
Study Title: Multi-level Analysis of Mouse and Human Neurons with the 22q11.2 Deletion